Surgery Partners Inc.
SGRY | NASDAQ
$14.96
+$1.30 (+9.52%)
Sep 22, 2026, 12:36 PM ET · Market open
Market Data
Market Cap $1.79B
Enterprise Value $5.59B
Beta 1.92
Average Volume 1.79M
Shares Outstanding (Diluted) 128.83M
Shares Change YoY 1.45%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US86881A1007
Price Performance
Price Change 1M -5.7%
Price Change 3M -6.0%
Price Change 6M 13.4%
Price Change YTD -10.5%
Price Change 1Y -37.5%
Price Change 3Y -54.5%
Price Change 5Y -67.5%
1M CAGR (ann.) -12.0%
1Y CAGR (ann.) -38.0%
5Y CAGR (ann.) -22.1%
All-Time CAGR -3.0%
Valuation
PE Ratio -19.80
Forward PE 27.92
PEG Ratio -0.50
Forward PEG -1.31
PS Ratio 0.53
Forward PS 0.50
PB Ratio 1.07
P/FCF Ratio 9.52
P/Adj. FCF Ratio 9.54
P/OCF Ratio 6.83
EV/Sales 1.66
EV/EBIT 7.25
EV/EBITDA 5.90
EV/FCF 29.78
Earnings Yield -5.0%
FCF Yield 10.5%
Adj. FCF Yield 10.5%
Financial Health
Net Debt $3.53B
Total Debt $4.02B
Cash & Short-Term Investments $216.7M
Total Assets $8.05B
Current Ratio 1.95
Quick Ratio 1.78
Debt / Equity Ratio 2.40
Debt / EBITDA 4.24
Debt / FCF 21.42
OCF / Debt 0.06
Interest Coverage 0.60
Altman Z-Score 0.88
Piotroski F-Score 5
Margins & Profitability
Gross Profit Margin 21.4%
Operating Profit Margin 11.9%
EBITDA Margin 28.1%
Net Profit Margin -2.6%
FCF Margin 5.6%
Adj. FCF Margin 5.6%
SBC / Revenue 0.0%
SBC Impact (per share) -0.2%
Returns
Return on Assets -1.1%
Return on Equity -5.2%
Return on Invested Capital 4.4%
Return on Capital Employed 5.4%
Return on Tangible Assets -3.2%
Historical Growth (CAGR)
Revenue CAGR 3Y 8.2%
Revenue CAGR 5Y 9.9%
Revenue CAGR 10Y 12.3%
EPS CAGR 3Y -26.4%
EPS CAGR 5Y -37.1%
EPS CAGR 10Y 9.1%
FCF CAGR 3Y 36.7%
FCF CAGR 5Y 38.1%
FCF CAGR 10Y 8.2%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 22
EPS Growth Next 3Y 60.4%
Revenue Growth Next 3Y 2.3%
Earnings Date Nov 8, 2026
EPS Estimate (next Q) $0.10
EPS Growth Est (next Q) -23.1%
Revenue Est (next Q) $848.48M
Revenue Growth Est (next Q) 3.3%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $18
Price Target Upside 31.8%
Cash Flow
Operating Cash Flow $258M
Free Cash Flow $187.6M
Adj. Free Cash Flow $187.2M
FCF Per Share $1.46
OCF Per Share $2
OCF/S Ratio 7.7%
Income Statement
Revenue $3.37B
Gross Profit $719.4M
Operating Income $400.4M
EBITDA $947.6M
Net Income $-88.6M
EPS (Diluted) -$0.69
Revenue / Employee $210.39K
Profit / Employee $-5.54K
Employees 16,000
Add to Watchlist
Select watchlists to add or remove SGRY